Charles Atisso
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 17
- Diabetes Management and Research 4
-
- Metabolism, Diabetes, and Cancer 14
- Peroxisome Proliferator-Activated Receptors 1
- Co-authors
- José Gerardo González‐González (2 shared papers)Whitney Sealls (2 shared papers)Jessie L. Fahrbach (2 shared papers)Santiago Tofé (2 shared papers)Thomas Först (2 shared papers)Kathleen Dungan (2 shared papers)Mark Lakshmanan (8 shared papers)Pedro García (3 shared papers)
- Journals
- Diabetes (3 papers)Cardiovascular Diabetology (2 papers)Diabetes Obesity and Metabolism (2 papers)Diabetes Care (2 papers)Canadian Journal of Diabetes (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Charles Atisso
16 papers receiving 840 citations
Charles Atisso's Hit Papers
Peers
Comparison fields: 5 of 55
- Endocrinology, Diabetes and Metabolism 812
- Pharmacology 244
- Molecular Biology 465
- Surgery 253
- Family Practice 9
Countries citing papers authored by Charles Atisso
This map shows the geographic impact of Charles Atisso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Atisso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Atisso more than expected).
Fields of papers citing papers by Charles Atisso
This network shows the impact of papers produced by Charles Atisso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Atisso. The network helps show where Charles Atisso may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Atisso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial Hit paper breakdown → | 2014 | 391 |
| 2 | 2014 | 321 | |
| 3 | 2016 | 49 | |
| 4 | 2021 | 42 | |
| 5 | 2021 | 18 | |
| 6 | 2020 | 12 | |
| 7 | 2023 | 7 | |
| 8 | 2013 | 6 | |
| 9 | 2019 | 5 | |
| 10 | 2014 | 4 | |
| 11 | 2020 | 3 | |
| 12 | 2020 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2020 | 1 | |
| 15 | 2013 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2018 | 0 | |
| 18 | 2014 | 0 |
About Charles Atisso
Charles Atisso is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Pharmacology and Oncology, having authored 18 papers that have together received 864 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (17 papers), Metabolism, Diabetes, and Cancer (14 papers), Diabetes Management and Research (4 papers), Pancreatic function and diabetes (3 papers), Pharmacology and Obesity Treatment (3 papers), Peptidase Inhibition and Analysis (2 papers), Platelet Disorders and Treatments (1 paper) and Peroxisome Proliferator-Activated Receptors (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (812 citations), Pharmacology (244 citations), Molecular Biology (465 citations), Surgery (253 citations) and Family Practice (9 citations). Charles Atisso has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include José Gerardo González‐González, Whitney Sealls, Jessie L. Fahrbach, Santiago Tofé, Thomas Först, Kathleen Dungan, Mark Lakshmanan, Pedro García, Richard F. Arakaki and Carol Wysham. Their work appears in journals such as Diabetes, Cardiovascular Diabetology, Diabetes Obesity and Metabolism, Diabetes Care and Canadian Journal of Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.